← 產業報告目錄
Non-Viral Transfection Reagents Market Size, Share & Trends Analysis Distribution by Type of Non-Viral Transfection System (Non-Viral Transfection Reagents (chemical & physical), Electroporation-based Transfection Systems), Area of Application (Clinical Applications, Research Applications), End-User (Academic and Research Institutions, Pharmaceutical Companies) and Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-08頁數 180報告編號 INSIGHTACE-b0f9b947d3
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Non-Viral Transfection Reagents Market stood at USD 649.1 Mn in 2023, and is forecasted to reach USD 1,157.5 Mn by 2031, recording a CAGR of 7.7% from 2024 through 2031.
The Non-Viral Transfection Reagents sector involves dynamics.
The market's upward path is underpinned by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Non-Viral Transfection Reagents Market Snapshot
Chapter 4. Global Non-Viral Transfection Reagents Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Non-Viral Transfection System Estimates & Trend Analysis
5.1. by Type of Non-Viral Transfection System & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Non-Viral Transfection System:
5.2.1. Non-Viral Transfection Reagents
5.2.1.1. Chemical-based Transfection
5.2.1.2. Physical Transfection Systems
5.2.2. Electroporation-based Transfection Systems
5.2.3. Other Non-Viral Transfection Systems
Chapter 6. Market Segmentation 2: by Area of Application Estimates & Trend Analysis
6.1. by Area of End-User & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Area of End-User:
6.2.1. Clinical End-Users
6.2.2. Research End-Users
Chapter 7. Market Segmentation 3: by End-User Estimates & Trend Analysis
7.1. by End-User & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User:
7.2.1. Academic and Research Institutions
7.2.2. Pharmaceutical Companies
7.2.3. Other End-Users
Chapter 8. Non-Viral Transfection Reagents Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type of Non-Viral Transfection System, 2023-2031
8.1.2. North America Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by Area of Application, 2023-2031
8.1.3. North America Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
8.1.4. North America Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.2. Europe
8.2.1. Europe Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type of Non-Viral Transfection System, 2023-2031
8.2.2. Europe Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by Area of Application, 2023-2031
8.2.3. Europe Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
8.2.4. Europe Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type of Non-Viral Transfection System, 2023-2031
8.3.2. Asia Pacific Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by Area of Application, 2023-2031
8.3.3. Asia-Pacific Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
8.3.4. Asia Pacific Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.4. Latin America
8.4.1. Latin America Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type of Non-Viral Transfection System, 2023-2031
8.4.2. Latin America Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by Area of Application, 2023-2031
8.4.3. Latin America Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
8.4.4. Latin America Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type of Non-Viral Transfection System, 2023-2031
8.5.2. Middle East & Africa Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by Area of Application, 2023-2031
8.5.3. Middle East & Africa Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
8.5.4. Middle East & Africa Non-Viral Transfection Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Altogen Biosystems
9.2.2. Bio-Rad Laboratories
9.2.3. BEX
9.2.4. BTX
9.2.5. Celsion
9.2.6. Genprex
9.2.7. Inovio Pharmaceuticals
9.2.8. MaxCyte
9.2.9. MilliporeSigma
9.2.10. Nepa Gene
9.2.11. OZ Biosciences
9.2.12. Thermo Fisher Scientific
9.2.13. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們